Clinical studies recruiting near Ahmedabad

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05268289 Magnetic Compression Anastomosis Procedure for Partial Jejunoileal Anastomosis: Assessing the Viability of an Innovative
NA · AB Plus Speciality Hospital · iIDEAS Group Holdings Limited · NCT07495787 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Hemato Oncology Clinic · Eli Lilly and Company · NCT06890598 A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06679101 Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Phase 3 · Research Site · AstraZeneca · NCT05624450 Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652 ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Phase 3 · Sardar Vallabhbhai Patel Institute of Medical Sciences and R · Novo Nordisk A/S · NCT06118281 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 2310 · Anthos Therapeutics, Inc. · NCT05712200 A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Phase 3 · Local Institution - 1255 · Bristol-Myers Squibb · NCT06937229 Efficacy of Hyperthermic Intraperitoneal Chemotherapy
Phase 3 · INDEPSO · Uppsala University · NCT04861558 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Phase 2 · Navneet Memorial Hospital SUSHRUSHA · Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli · NCT06226883 A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)
Phase 1 · Cellcure Care Cancer Pvt Ltd · Aurigene Discovery Technologies Limited · NCT05984147 A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standa
Phase 3 · Research Site · AstraZeneca · NCT06455449 A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Par
Phase 3 · Marengo Cims Hospital · Janssen Research & Development, LLC · NCT06807424 A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07431177 Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
NA · EPIC Hospital · Unity Health Toronto · NCT04754022 A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Phase 3 · Zydus Hospital · Biogen · NCT06935357 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure P
Phase 3 · Ahmedabad, Gujarat Investigative Site 51006 · Colorado Prevention Center · NCT06008197 LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Phase 2 · Sardar Vallabhbhai Patel Institute of Medical Sciences and R · Eli Lilly and Company · NCT07186101 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants Wi
Phase 3 · Research Site · AstraZeneca · NCT05211895 International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Phase N/A · Investigational Site Number : 356003 · Genzyme, a Sanofi Company · NCT00358943 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Heamto Oncology Clinic Ahmedabad Pvt. Ltd. · Takeda · NCT06499285 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1-14IL3BK3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363 A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)
Phase N/A · Zydus Hospitals · Translumina Therapeutics Pvt Ltd. · NCT06412250 A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
Phase 4 · Cims Hospital · Johnson & Johnson Private Limited · NCT07141004 Magnetic Compression Anastomosis Procedure for Partial Jejuno-ileal Diversion: Evaluating the Feasibility of a Novel End
NA · AB Plus Speciality Hospital · iIDEAS Group Holdings Limited · NCT07350967 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Local Institution - 007-1574 · Mirati Therapeutics Inc. · NCT04613596 A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Phase 1 · Apollo Hospital International Limited · Aurigene Discovery Technologies Limited · NCT05865002

Look up another city

Look up another condition